Immunotherapy leveraging mature DCs has been shown to augment the populations of CD8+ and CD4+ T cells, curb the growth of breast tumors through the induction of apoptosis and anti-mitotic mechanisms, and thwart metastasis by reducing the expression of the transcription factors Snail, Slug, and Twist (79). This evidence concerns the gene CD8A and breast neoplasm.